Liver Cancer (Primary and Metastatic)
Conditions
Brief summary
This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin
Interventions
PROCEDUREliver resection
Patients undergo liver resection for tumor.
DRUGSystemic therapy combined with locoregional interventions
Patients recieve PD-1 inhibitors combined with targeted drugs and locoregional interventions
Sponsors
Tongji Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male or female aged ≥18 years at the time of signing the informed consent form * Clinically or histologically confirmed diagnosis of liver cancer * Recieving treatment and follow-up in Tongji Hospital
Exclusion criteria
\- Refuse participanting in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival | From date of treatment until the date of death from any cause, assessed up to 100 months |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Adverse Events | Within 30 days following interventions |
Countries
China
Contacts
CONTACTQi Cheng, M.D.
Outcome results
None listed